VC-backed OnSite Labs to invest $5 mln in diagnostics provider MedMira
MedMira Inc (TSX-V: MIR), a developer and manufacturer of rapid flow-through diagnostics technology, has entered into an agreement to secure $5 million from OnSite Lab Holding AG, the company's controlling investor. Halifax-based MedMira said it will use the proceeds of the deal to strategically capitalize on the potential of its technology, which provides hospitals, labs, clinics and individuals with instant diagnosis for diseases such as HIV and Hepatitis C. OnSite, which has previously invested $18.7 million in MedMira, is a portfolio company of European venture capital firm Redalpine Venture Partners.
3 September 2015•4 mins read
